Bio-Rad Laboratories P/E Ratio

The latest P/E ratio for BIO.B is 9.6. That is below the Healthcare sector average of 22.57. Investors often review this figure alongside Bio-Rad Laboratories's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, BIO.B currently prints 9.6 for P/E ratio, while the sector average sits near 22.57. That is roughly 57.5% below the sector mean. Large gaps often invite a closer look at Bio-Rad Laboratories's growth, margins, and balance sheet.

A P/E ratio of 9.6 for Bio-Rad Laboratories is not 'good' or 'bad' on its own. Compare it with the peer average (22.57) and with BIO.B's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting BIO.B's P/E ratio (9.6), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Bio-Rad Laboratories's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.